Suvorexant

Category: sleep

Aliases: Belsomra

Pharmacological Mechanism

Dual OX1R + OX2R antagonist. Orexin signalling from the hypothalamic lateral nucleus drives wakefulness; blocking it produces hypnosis through a mechanism distinct from GABA potentiation → no GABA-related side effects (no dependence liability as severe as BZs; Schedule IV due to modest abuse potential).

Half-Life (t½)

PO: 12h

Dosing Guidelines

Target Organ Systems